Apo E2 (substitution of cysteine in the normal Apo E3 variant for arginine at residue 158) interacts poorly with LDLR and LDLR-related protein, thereby DLP and an increased risk for atherosclerosis [28]. This evidence concerns the gene LDLR and atherosclerosis.